How Do You Build a Start-Up into a $600 Million Exit? We Ask Matt Likens, Former CEO of Ulthera

The board at Ulthera, an aesthetics device company, faced an attractive dilemma. Take the company public? Or accept a lucrative buyout? Hear from the CEO how the company’s culture and approach led to that favorable outcome.